Clinical Trial Update: Alternate Day Buprenorphine Administration, Phase IX - 14 [Phase 2]

View source ↗

Summary

Phase II trial evaluating alternate-day buprenorphine administration for opioid-related disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-related Disorders

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: University of Vermont | Conditions: Opioid-Related Disorders | Phase 2 | Status: COMPLETED